With the U.S. unemployment rate sitting at 4.1% and inflation still above the Fed’s 2% target, investors are watching how longer lasting tight monetary policy could ripple through everything from paychecks to pantry staples. That mix can reshape which consumer stocks feel pressure and which hold up. This article breaks down three large consumer staples stocks exposed to these trends and why they may deserve a closer look now.

The three stocks highlighted below are just a sample. The full screen surfaced 21 more large US consumer staples companies with equally compelling stories that are not covered here. To identify and analyze the setups that best fit your own thesis, head straight into the US Consumer Staples Stocks screener.

USANA Health Sciences (USNA)

USANA Health Sciences develops and sells science-based nutritional supplements, meal replacements, and skincare products to consumers across Asia Pacific, the Americas, and Europe through direct selling, subscriptions, and online channels. Its Core nutritional segment is the main engine, generating about US$761 million in revenue, while the Hiya direct to consumer segment contributes roughly US$121 million. The company is relatively small in market terms, with a market cap of about US$286 million.

USANA Health Sciences sits at the crossroads of everyday wellness spending and tighter household budgets. This positioning can make it an interesting consumer staples stock to watch as rates stay high and US unemployment remains low. The core business is under pressure, with recent goodwill impairments and guidance cuts highlighting that reliance on Asia and a direct selling model brings regulatory and distributor risks. At the same time, some analysts describe a potential path back to profitability, and some value screens flag the stock as trading well below certain estimates of fair value, while new index additions could support liquidity. For investors seeking exposure to vitamins and supplements and who are willing to accept volatility and execution risk, this may be a story to research more closely.

USANA Health Sciences looks like a value story that many investors may be underestimating, with goodwill impairments and guidance cuts possibly masking the full picture in the DCF valuation analysis for USANA Health Sciences that hints at what the market might be missing.

Build your own value and quality shortlist

USANA Health Sciences and the other two consumer staples stocks in this list came from applying a few simple filters, which you can customise even further. Use our flexible Screener to combine valuation, quality, balance sheet and risk filters around your own thesis, or tap straight into our curated Investing Ideas for ready made starting points.

Vital Farms (VITL)

Vital Farms is a U.S. food company that focuses on pasture raised shell eggs, butter and related products sourced from animals raised on family farms, selling through retailers and foodservice channels under its own brand and other labels. All of its reported US$765 million in revenue comes from a single Eggs and Butter segment in the United States, so the business is tightly focused on one core category and market. The company currently has a market cap of about US$525 million, placing it firmly in small cap territory.

Vital Farms sits squarely in consumer staples, supplying everyday eggs and butter that many households keep buying even when rates stay high and budgets feel tight. The draw is a premium, ethics focused brand that has built strong loyalty and pricing power, supported by heavier marketing and a growing farm and production network. That comes with real trade offs. Recent results show a swing from profits to losses, razor thin margins and higher borrowing to fund capacity and share buybacks, which could bite if demand or pricing softens. For investors who want exposure to branded food with a clear identity and are comfortable with execution and funding risk, this is a story worth watching more closely.

Vital Farms’ premium story and tight margins create an intriguing mix for a small cap food stock that many investors may be overlooking. Get the full picture in the 2 key rewards and 2 important warning signs (1 is major!)

Boston Beer Company (SAM)

Boston Beer Company is a U.S. brewer and alcohol producer best known for Samuel Adams Boston Lager, Twisted Tea, Truly, Angry Orchard, Dogfish Head and newer spirits based ready to drink products. The business generated about US$1.9b in revenue from alcohol beverages alone and sells primarily through wholesalers into grocery stores, liquor stores, bars, restaurants and online channels in the United States and abroad. The company has a market cap of roughly US$1.9b, putting it in mid cap territory.

Boston Beer Company provides exposure to a portfolio of well known alcohol brands that continue to reach shoppers even when interest rates stay high and budgets feel tighter. Management is focusing on new hard teas, seltzers and spirits based drinks, while cost controls and brewery efficiency have lifted gross margins even as Q2 2026 volumes and earnings came under pressure. The stock trades around 1x sales, and analysts currently anticipate a recovery in earnings from current losses over the next few years. Recent guidance cuts and softer demand in Twisted Tea and Truly remain key risks. This mix of premium brands, margin progress and an uncertain outlook makes Boston Beer Company a consumer staple that may warrant closer attention.

Boston Beer Company’s brand strength and focus on margins may be creating a risk-reward profile that differs from what its US$1.9b market cap might indicate. Get the full story in the analysis report for Boston Beer Company

Seeking Fresh Alternatives Before Others Do

Markets move fast and the best setups rarely stay quiet for long. Spot fresh momentum, potential breakouts and stocks still under the radar for now. Act now.

• Spot companies with strong cash flows and stability, then run them through the 52 high quality undervalued stocks while the crowd is still focused elsewhere.
• Ride growth in data, chips and infrastructure by scanning the 56 AI infrastructure stocks before these stories start flying across every headline.
• Position ahead of new automation trends by checking the 37 robotics and automation stocks while these opportunities remain under owned and prices still look reasonable.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.